{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:48:23Z","timestamp":1794023303648,"version":"4.8.0"},"reference-count":179,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s12022-022-09708-2","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T05:04:03Z","timestamp":1647407043000},"page":"115-154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1028,"title":["Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2996-4404","authenticated-orcid":false,"given":"Guido","family":"Rindi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0469-2801","authenticated-orcid":false,"given":"Ozgur","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5714-7295","authenticated-orcid":false,"given":"Silvia","family":"Uccella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2747-1366","authenticated-orcid":false,"given":"Olca","family":"Basturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1941-2403","authenticated-orcid":false,"given":"Stefano","family":"La Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1341-8994","authenticated-orcid":false,"given":"Lodewijk A. A.","family":"Brosens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1463-5165","authenticated-orcid":false,"given":"Wouter W.","family":"de Herder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8814-1702","authenticated-orcid":false,"given":"David S.","family":"Klimstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2713-1700","authenticated-orcid":false,"given":"Mauro","family":"Papotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8418-5054","authenticated-orcid":false,"given":"Sylvia L.","family":"Asa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"9708_CR1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1113\/jphysiol.1902.sp000920","volume":"28","author":"WM Bayliss","year":"1902","unstructured":"Bayliss WM, Starling EH (1902) The mechanism of pancreatic secretion. J Physiol 28: 325-353.","journal-title":"J Physiol"},{"key":"9708_CR2","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1097\/00000658-190912000-00003","volume":"50","author":"H Cushing","year":"1909","unstructured":"Cushing H (1909) III. Partial Hypophysectomy for Acromegaly: With Remarks on the Function of the Hypophysis. Ann Surg 50: 1002-1017. https:\/\/doi.org\/10.1097\/00000658-190912000-00003 [doi].","journal-title":"Ann Surg"},{"key":"9708_CR3","first-page":"371","volume":"24","author":"O Minkowski","year":"1887","unstructured":"Minkowski O (1887) Ueber einen Fall von Akromegalie. Berl Klin Wochenschr 24: 371-374.","journal-title":"Berl Klin Wochenschr"},{"key":"9708_CR4","first-page":"425","volume":"1","author":"S Oberndorfer","year":"1907","unstructured":"Oberndorfer S (1907) Karzinoide tumoren des D\u00fcnndarms. Frankfurter Zeitschrift f\u00fcr Pathologie 1: 425-432.","journal-title":"Frankfurter Zeitschrift f\u00fcr Pathologie"},{"key":"9708_CR5","doi-asserted-by":"publisher","unstructured":"Thorson A, Biorck G, Bjorkman G, Waldenstrom J (1954) Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis; a clinical and pathologic syndrome. Am Heart J 47: 795\u2013817. 0002\u20138703(54)90152\u20130 ; https:\/\/doi.org\/10.1016\/0002-8703(54)90152-0.","DOI":"10.1016\/0002-8703(54)90152-0"},{"key":"9708_CR6","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S0140-6736(00)64173-9","volume":"136","author":"W Ransom","year":"1890","unstructured":"Ransom W (1890) A case of primary carcinoma of the ileum. Lancet 136: 1020-1023.","journal-title":"Lancet"},{"key":"9708_CR7","doi-asserted-by":"crossref","unstructured":"Asa SL, Lloyd RV, Tischler AS (2021) Neuroendocrine neoplasms: Historical background and terminologies. In: Asa SL, La Rosa S, Mete O, editors. The Spectrum of Neuroendocrine Neoplasia. Cham, Switzerland: Springer Nature. pp. 1\u201314.","DOI":"10.1007\/978-3-030-54391-4_1"},{"key":"9708_CR8","unstructured":"Travis, W. D., Burke, A. P., Marx, A., and Nicholson, A. G. (2015) WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC."},{"key":"9708_CR9","unstructured":"Bosman FT, Carneiro F, Hruban RH, Teiise ND (2010) WHO Classification of Tumours of the Gastrointestinal Tract."},{"key":"9708_CR10","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","volume":"31","author":"G Rindi","year":"2018","unstructured":"Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, Busam KJ, de Krijger RR, Dietel M, El-Naggar AK, Fernandez-Cuesta L, Kloppel G, McCluggage WG, Moch H, Ohgaki H, Rakha EA, Reed NS, Rous BA, Sasano H, Scarpa A, Scoazec JY, Travis WD, Tallini G, Trouillas J, van Krieken JH, Cree IA (2018) A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 31: 1770-1786. https:\/\/doi.org\/10.1038\/s41379-018-0110-y.","journal-title":"Mod Pathol"},{"key":"9708_CR11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nrendo.2011.120","volume":"8","author":"G Rindi","year":"2011","unstructured":"Rindi G, Wiedenmann B (2011) Neuroendocrine neoplasms of the gut and pancreas: new insights. Nat Rev Endocrinol 8: 54-64. https:\/\/doi.org\/10.1038\/nrendo.2011.120.","journal-title":"Nat Rev Endocrinol"},{"key":"9708_CR12","doi-asserted-by":"publisher","unstructured":"Rosenbaum JN, Guo Z, Baus RM, Werner H, Rehrauer WM, Lloyd RV (2015) INSM1: A Novel Immunohistochemical and Molecular Marker for Neuroendocrine and Neuroepithelial Neoplasms. Am J Clin Pathol 144: 579\u2013591. 144\/4\/579; https:\/\/doi.org\/10.1309\/AJCPGZWXXBSNL4VD.","DOI":"10.1309\/AJCPGZWXXBSNL4VD"},{"key":"9708_CR13","doi-asserted-by":"crossref","unstructured":"Mete O, Asa SL, Gill AJ, Kimuta N, deKrijger R, Tischler A (2022) Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas. Endocr Pathol.","DOI":"10.1007\/s12022-022-09704-6"},{"key":"9708_CR14","first-page":"16","volume-title":"WHO Classification od Tumours Editorial Board","author":"D Klimstra","year":"2019","unstructured":"Klimstra D, Kloppel G, La Rosa S, Rindi G (2019) Classification of neuroendocrine neoplasms of the digestive system. In: WHO Classification od Tumours Editorial Board, editors. Digestive System Tumours. Lyon: IARC Press. pp. 16-19."},{"key":"9708_CR15","first-page":"109","volume-title":"WHO Classification of Tumours Editorial Board","author":"WD Travis","year":"2022","unstructured":"Travis WD, Beasley M, Cree I, Papotti M, Rekhtman N, et al. (2022) Lung Neuroendocrine Neoplasms. In: WHO Classification of Tumours Editorial Board, editors. Thoracic Tumours. Lyon: IARC Press. pp. 109-111."},{"key":"9708_CR16","unstructured":"WHO Classification of Tumours Editorial Board (2022) WHO classification of endocrine and neuroendocrine tumours. Lyon, France: IARC."},{"key":"9708_CR17","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1210\/mend-3-10-1589","volume":"3","author":"DJ Drucker","year":"1989","unstructured":"Drucker DJ, Asa SL, Henderson J, Goltzman D (1989) The parathyroid hormone-like peptide gene is expressed in the normal and neoplastic human endocrine pancreas. Mol Endocrinol 3: 1589-1595.","journal-title":"Mol Endocrinol"},{"key":"9708_CR18","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1210\/jcem-71-5-1112","volume":"71","author":"SL Asa","year":"1990","unstructured":"Asa SL, Henderson J, Goltzman D, Drucker DJ (1990) Parathyroid hormone-like peptide in normal and neoplastic human endocrine tissues. J Clin Endocrinol Metab 71: 1112-1118.","journal-title":"J Clin Endocrinol Metab"},{"key":"9708_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/1097-0142(19930101)71:1<66::AID-CNCR2820710112>3.0.CO;2-U","volume":"71","author":"S Ezzat","year":"1993","unstructured":"Ezzat S, Ezrin C, Yamashita S, Melmed S (1993) Recurrent acromegaly resulting from ectopic growth hormone gene expression by a metastatic pancreatic tumor. Cancer 71: 66-70.","journal-title":"Cancer"},{"key":"9708_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12022-017-9492-5","volume":"29","author":"OM Alshaikh","year":"2018","unstructured":"Alshaikh OM, Yoon JY, Chan BA, Krzyzanowska MK, Butany J, Asa SL, Ezzat S (2018) Pancreatic Neuroendocrine Tumor Producing Insulin and Vasopressin. Endocr Pathol 29: 15-20. https:\/\/doi.org\/10.1007\/s12022-017-9492-5.","journal-title":"Endocr Pathol"},{"key":"9708_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/ajcp\/87.3.327","volume":"87","author":"SL Asa","year":"1987","unstructured":"Asa SL, Kovacs K, Vale W, Petrusz P, Vecsei P (1987) Immunohistologic localization of corticotrophin-releasing hormone in human tumors. Am J Clin Pathol 87: 327-333.","journal-title":"Am J Clin Pathol"},{"key":"9708_CR22","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/PAS.0000000000000340","volume":"39","author":"R Maragliano","year":"2015","unstructured":"Maragliano R, Vanoli A, Albarello L, Milione M, Basturk O, Klimstra DS, Wachtel A, Uccella S, Vicari E, Milesi M, Davi MV, Scarpa A, Sessa F, Capella C, La Rosa S (2015) ACTH-secreting pancreatic neoplasms associated with Cushing syndrome: clinicopathologic study of 11 cases and review of the literature. Am J Surg Pathol 39: 374-382. https:\/\/doi.org\/10.1097\/PAS.0000000000000340.","journal-title":"Am J Surg Pathol"},{"key":"9708_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12022-015-9384-5","volume":"26","author":"A Fountas","year":"2015","unstructured":"Fountas A, Giotaki Z, Ligkros N, Tsakiridou ED, Tigas S, Saeger W, Tsatsoulis A (2015) Cushing\u2019s Syndrome Due to CRH and ACTH Co-secreting Pancreatic Tumor--Presentation of a New Case Focusing on Diagnostic Pitfalls. Endocr Pathol 26: 239-242. https:\/\/doi.org\/10.1007\/s12022-015-9384-5.","journal-title":"Endocr Pathol"},{"key":"9708_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070397","volume":"8","author":"Y Suissa","year":"2013","unstructured":"Suissa Y, Magenheim J, Stolovich-Rain M, Hija A, Collombat P, Mansouri A, Sussel L, Sosa-Pineda B, McCracken K, Wells JM, Heller RS, Dor Y, Glaser B (2013) Gastrin: a distinct fate of neurogenin3 positive progenitor cells in the embryonic pancreas. PLoS ONE 8: e70397. https:\/\/doi.org\/10.1371\/journal.pone.0070397.","journal-title":"PLoS ONE"},{"key":"9708_CR25","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1210\/jc.2014-1315","volume":"99","author":"K Kamp","year":"2014","unstructured":"Kamp K, Feelders RA, van Adrichem RC, de Rijke YB, van Nederveen FH, Kwekkeboom DJ, de Herder WW (2014) Parathyroid hormone-related peptide (PTHrP) secretion by gastroenteropancreatic neuroendocrine tumors (GEP-NETs): clinical features, diagnosis, management, and follow-up. J Clin Endocrinol Metab 99: 3060-3069. https:\/\/doi.org\/10.1210\/jc.2014-1315.","journal-title":"J Clin Endocrinol Metab"},{"key":"9708_CR26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1210\/edrv-9-3-357","volume":"9","author":"T Sano","year":"1988","unstructured":"Sano T, Asa SL, Kovacs K (1988) Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. Endocr Rev 9: 357-373.","journal-title":"Endocr Rev"},{"key":"9708_CR27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2220\/biomedres.8.407","volume":"8","author":"T Sano","year":"1987","unstructured":"Sano T, Saito H, Yamasaki R, Kimura N, Sasaki A, Hirose T, Hizawa K, Saito S (1987) Immunoreactivity against anti-growth hormone-releasing hormone (GHRH) sera in human pancreas and pancreatic endocrine tumors: Evidence of pitfall in immunohistochemical study. Biomed Res 8: 407-414.","journal-title":"Biomed Res"},{"key":"9708_CR28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s12022-017-9505-4","volume":"28","author":"S Uccella","year":"2017","unstructured":"Uccella S, Blank A, Maragliano R, Sessa F, Perren A, La Rosa S (2017) Calcitonin-Producing Neuroendocrine Neoplasms of the Pancreas: Clinicopathological Study of 25 Cases and Review of the Literature. Endocr Pathol 28: 351-361. https:\/\/doi.org\/10.1007\/s12022-017-9505-4.","journal-title":"Endocr Pathol"},{"key":"9708_CR29","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1200\/JCO.2004.10.031","volume":"22","author":"I Samyn","year":"2004","unstructured":"Samyn I, Fontaine C, Van TF, Pipeleers-Marichal M, De GJ (2004) Paraneoplastic syndromes in cancer: Case 1. Polycythemia as a result of ectopic erythropoietin production in metastatic pancreatic carcinoid tumor. J Clin Oncol 22: 2240-2242. https:\/\/doi.org\/10.1200\/JCO.2004.10.031.","journal-title":"J Clin Oncol"},{"key":"9708_CR30","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0140-6736(14)62294-7","volume":"385","author":"AD Miras","year":"2015","unstructured":"Miras AD, Mogford JT, Wright J, Mendoza NN, Xekouki P, Lakhani A, Pellegata NS, Stratakis CA, Roncaroli F, Russell-Jones D (2015) Ovarian hyperstimulation from ectopic hypersecretion of follicle stimulating hormone. Lancet 385: 392. https:\/\/doi.org\/10.1016\/S0140-6736(14)62294-7.","journal-title":"Lancet"},{"key":"9708_CR31","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1210\/jc.2003-032029","volume":"90","author":"G Piaditis","year":"2005","unstructured":"Piaditis G, Angellou A, Kontogeorgos G, Mazarakis N, Kounadi T, Kaltsas G, Vamvakidis K, Lloyd RV, Horvath E, Kovacs K (2005) Ectopic bioactive luteinizing hormone secretion by a pancreatic endocrine tumor, manifested as luteinized granulosa-thecal cell tumor of the ovaries. J Clin Endocrinol Metab 90: 2097-2103. https:\/\/doi.org\/10.1210\/jc.2003-032029.","journal-title":"J Clin Endocrinol Metab"},{"key":"9708_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/BF03351063","volume":"27","author":"E Brignardello","year":"2004","unstructured":"Brignardello E, Manti R, Papotti M, Allia E, Campra D, Isolato G, Cassinis MC, Fronda G, Boccuzzi G (2004) Ectopic secretion of LH by an endocrine pancreatic tumor. J Endocrinol Invest 27: 361-365.https:\/\/doi.org\/10.1007\/BF03351063 .","journal-title":"J Endocrinol Invest"},{"key":"9708_CR33","doi-asserted-by":"crossref","unstructured":"Mete O, Hannah-Shmouni F, Kim R, Stratakis C (2021) Inherited neuroendocrine neoplasms. In: Asa SL, La Rosa S, Mete O, editors. The Spectrum of Neuroendocrine Neoplasia. Cham, Switzerland: Springer Nature. pp. 409\u2013460.","DOI":"10.1007\/978-3-030-54391-4_18"},{"key":"9708_CR34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3389\/fonc.2018.00291","volume":"8","author":"Y Okubo","year":"2018","unstructured":"Okubo Y, Yoshioka E, Suzuki M, Washimi K, Kawachi K, Kameda Y, Yokose T (2018) Diagnosis, Pathological Findings, and Clinical Management of Gangliocytic Paraganglioma: A Systematic Review. Front Oncol 8: 291. https:\/\/doi.org\/10.3389\/fonc.2018.00291.","journal-title":"Front Oncol"},{"key":"9708_CR35","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00401-020-02221-y","volume":"140","author":"B Ramani","year":"2020","unstructured":"Ramani B, Gupta R, Wu J, Barreto J, Bollen AW, Tihan T, Mummaneni PV, Ames C, Clark A, Oberheim Bush NA, Butowski N, Phillips D, King BE, Bator SM, Treynor EC, Zherebitskiy V, Quinn PS, Walker JB, Pekmezci M, Sullivan DV, Hofmann JW, Sloan EA, Chang M, Berger MS, Solomon DA, Perry A (2020) The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma. Acta Neuropathol 140: 907-917. https:\/\/doi.org\/10.1007\/s00401-020-02221-y.","journal-title":"Acta Neuropathol"},{"key":"9708_CR36","doi-asserted-by":"publisher","first-page":"5573926","DOI":"10.1210\/endrev\/bnz004","volume":"41","author":"J Hofland","year":"2020","unstructured":"Hofland J, Kaltsas G, de Herder WW (2020) Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms. Endocr Rev 41: 5573926. https:\/\/doi.org\/10.1210\/endrev\/bnz004.","journal-title":"Endocr Rev"},{"key":"9708_CR37","doi-asserted-by":"crossref","unstructured":"Chbat J, Amer L, Akirov A, Ezzat S (2021) The diagnosis of neuroendocrine neoplasms. In: Asa SL, La Rosa S, Mete O, editors. The Spectrum of Neuroendocrine Neoplasia. Cham, Switzerland: Springer Nature. pp. 15\u201328.","DOI":"10.1007\/978-3-030-54391-4_2"},{"key":"9708_CR38","doi-asserted-by":"publisher","unstructured":"Asa\u00a0SL , Ezzat\u00a0S, Mete\u00a0O (2018) The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations J Clin Med 7.https:\/\/doi.org\/10.3390\/jcm7090280","DOI":"10.3390\/jcm7090280"},{"key":"9708_CR39","doi-asserted-by":"publisher","unstructured":"Akirov\u00a0A, Asa\u00a0SL, Amer\u00a0L, Shimon\u00a0I, Ezzat\u00a0S (2019) The Clinicopathological Spectrum of Acromegaly J Clin Med 8.https:\/\/doi.org\/10.3390\/jcm8111962","DOI":"10.3390\/jcm8111962"},{"key":"9708_CR40","doi-asserted-by":"crossref","unstructured":"Dromain C, Prior JO, Schaefer N (2021) Functional and radiological imaging of neuroendocrine neoplasms. In: Asa SL, La Rosa S, Mete O, editors. The Spectrum of Neuroendocrine Neoplasia. Cham, Switzerland: Spinder Nature. pp. 29\u201354.","DOI":"10.1007\/978-3-030-54391-4_3"},{"key":"9708_CR41","doi-asserted-by":"publisher","unstructured":"Akirov\u00a0A, Larouche\u00a0V, Alshehri\u00a0S, Asa\u00a0SL, Ezzat\u00a0S (2019) Treatment Options for Pancreatic Neuroendocrine Tumors Cancers (Basel) 11.https:\/\/doi.org\/10.3390\/cancers11060828","DOI":"10.3390\/cancers11060828"},{"key":"9708_CR42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1053\/j.semnuclmed.2020.04.001","volume":"50","author":"JR Buscombe","year":"2020","unstructured":"Buscombe JR (2020) Evidence Base for the Use of PRRT. Semin Nucl Med 50: 399-404. https:\/\/doi.org\/10.1053\/j.semnuclmed.2020.04.001.","journal-title":"Semin Nucl Med"},{"key":"9708_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13550-020-00623-3","volume":"10","author":"AR Haug","year":"2020","unstructured":"Haug AR (2020) PRRT of neuroendocrine tumors: individualized dosimetry or fixed dose scheme? EJNMMI Res 10: 35. https:\/\/doi.org\/10.1186\/s13550-020-00623-3.","journal-title":"EJNMMI Res"},{"key":"9708_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11864-020-0711-9","volume":"21","author":"S Shaheen","year":"2020","unstructured":"Shaheen S, Moradi F, Gamino G, Kunz PL (2020) Patient Selection and Toxicities of PRRT for Metastatic Neuroendocrine Tumors and Research Opportunities. Curr Treat Options Oncol 21: 25. https:\/\/doi.org\/10.1007\/s11864-020-0711-9.","journal-title":"Curr Treat Options Oncol"},{"key":"9708_CR45","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1038\/s41379-020-0517-0","volume":"33","author":"HK Tsai","year":"2020","unstructured":"Tsai HK, Hornick JL, Vivero M (2020) INSM1 expression in a subset of thoracic malignancies and small round cell tumors: rare potential pitfalls for small cell carcinoma. Mod Pathol 33: 1571-1580. https:\/\/doi.org\/10.1038\/s41379-020-0517-0.","journal-title":"Mod Pathol"},{"key":"9708_CR46","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.surg.2018.04.044","volume":"164","author":"JJ Kanitra","year":"2018","unstructured":"Kanitra JJ, Hardaway JC, Soleimani T, Koehler TJ, McLeod MK, Kavuturu S (2018) Adrenocortical oncocytic neoplasm: A systematic review. Surgery 164: 1351-1359. https:\/\/doi.org\/10.1016\/j.surg.2018.04.044.","journal-title":"Surgery"},{"key":"9708_CR47","doi-asserted-by":"publisher","first-page":"8596","DOI":"10.3748\/wjg.v22.i38.8596","volume":"22","author":"Y Ohara","year":"2016","unstructured":"Ohara Y, Oda T, Hashimoto S, Akashi Y, Miyamoto R, Enomoto T, Satomi K, Morishita Y, Ohkohchi N (2016) Pancreatic neuroendocrine tumor and solid-pseudopapillary neoplasm: Key immunohistochemical profiles for differential diagnosis. World J Gastroenterol 22: 8596-8604. https:\/\/doi.org\/10.3748\/wjg.v22.i38.8596.","journal-title":"World J Gastroenterol"},{"key":"9708_CR48","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41574-020-0391-3","volume":"16","author":"G Rindi","year":"2020","unstructured":"Rindi G, Wiedenmann B (2020) Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine. Nat Rev Endocrinol 16: 590-607. https:\/\/doi.org\/10.1038\/s41574-020-0391-3.","journal-title":"Nat Rev Endocrinol"},{"key":"9708_CR49","volume-title":"Survival Guide to Endocrine Pathology","author":"SL Asa","year":"2020","unstructured":"Asa, S. L. (2020) Survival Guide to Endocrine Pathology. Virginia: Innovative Pathology Press."},{"key":"9708_CR50","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/cncy.21765","volume":"124","author":"K Duan","year":"2016","unstructured":"Duan K, Mete O (2016) Algorithmic approach to neuroendocrine tumors in targeted biopsies: Practical applications of immunohistochemical markers. Cancer Cytopathol 124: 871-884. https:\/\/doi.org\/10.1002\/cncy.21765.","journal-title":"Cancer Cytopathol"},{"key":"9708_CR51","doi-asserted-by":"crossref","unstructured":"Uccella S, Asa SL, Mete O (2020) Neuroendocrine neoplasms of unknown primary site. In: Asa SL, La Rosa S, Mete O, editors. The Spectrum of Neuroendocrine Neoplasia. Springer.","DOI":"10.1007\/978-3-030-54391-4_16"},{"key":"9708_CR52","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12022-018-9522-y","volume":"29","author":"S Uccella","year":"2018","unstructured":"Uccella S, La Rosa S, Volante M, Papotti M (2018) Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms. Endocr Pathol 29: 150-168. https:\/\/doi.org\/10.1007\/s12022-018-9522-y.","journal-title":"Endocr Pathol"},{"key":"9708_CR53","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41379-018-0167-7","volume":"32","author":"O Mete","year":"2019","unstructured":"Mete O, Kefeli M, Caliskan S, Asa SL (2019) GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors. Mod Pathol 32: 484-489. https:\/\/doi.org\/10.1038\/s41379-018-0167-7.","journal-title":"Mod Pathol"},{"key":"9708_CR54","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/s41379-021-00820-y","volume":"34","author":"SL Asa","year":"2021","unstructured":"Asa SL, Mete O, Cusimano MD, McCutcheon IE, Perry A, Yamada S, Nishioka H, Casar-Borota O, Uccella S, La Rosa S, Grossman AB, Ezzat S (2021) Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification. Mod Pathol 34: 1634-1650. https:\/\/doi.org\/10.1038\/s41379-021-00820-y.","journal-title":"Mod Pathol"},{"key":"9708_CR55","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12022-018-9532-9","volume":"29","author":"Z Baloch","year":"2018","unstructured":"Baloch Z, Mete O, Asa SL (2018) Immunohistochemical Biomarkers in Thyroid Pathology. Endocr Pathol 29: 91-112. https:\/\/doi.org\/10.1007\/s12022-018-9532-9.","journal-title":"Endocr Pathol"},{"key":"9708_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12022-019-09603-3","volume":"31","author":"H Gucer","year":"2020","unstructured":"Gucer H, Caliskan S, Kefeli M, Mete O (2020) Do You Know the Details of Your PAX8 Antibody? Monoclonal PAX8 (MRQ-50) Is Not Expressed in a Series of 45 Medullary Thyroid Carcinomas. Endocr Pathol 31: 33-38. https:\/\/doi.org\/10.1007\/s12022-019-09603-3.","journal-title":"Endocr Pathol"},{"key":"9708_CR57","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/PAI.0000000000000149","volume":"24","author":"JY Liau","year":"2016","unstructured":"Liau JY, Tsai JH, Jeng YM, Kuo KT, Huang HY, Liang CW, Yang CY (2016) The Diagnostic Utility of PAX8 for Neuroendocrine Tumors: An Immunohistochemical Reappraisal. Appl Immunohistochem Mol Morphol 24: 57-63. https:\/\/doi.org\/10.1097\/PAI.0000000000000149.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"9708_CR58","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12022-018-9527-6","volume":"29","author":"LA Erickson","year":"2018","unstructured":"Erickson LA, Mete O (2018) Immunohistochemistry in Diagnostic Parathyroid Pathology. Endocr Pathol 29: 113-129. https:\/\/doi.org\/10.1007\/s12022-018-9527-6.","journal-title":"Endocr Pathol"},{"key":"9708_CR59","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/his.14012","volume":"76","author":"D Hoskoppal","year":"2020","unstructured":"Hoskoppal D, Epstein JI, Gown AM, Arnold Egloff SA, Gordetsky JB, Shi CJ, Giannico GA (2020) SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours. Histopathology 76: 550-559. https:\/\/doi.org\/10.1111\/his.14012.","journal-title":"Histopathology"},{"key":"9708_CR60","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322595","author":"WM Hackeng","year":"2021","unstructured":"Hackeng WM, Brosens LAA, Kim JY, O'Sullivan R, Sung YN, Liu TC, Cao D, Heayn M, Brosnan-Cashman J, An S, Morsink FHM, Heidsma CM, Valk GD, Vriens MR, Nieveen van DE, Offerhaus GJA, Dreijerink KMA, Zeh H, Zureikat AH, Hogg M, Lee K, Geller D, Marsh JW, Paniccia A, Ongchin M, Pingpank JF, Bahary N, Aijazi M, Brand R, Chennat J, Das R, Fasanella KE, Khalid A, McGrath K, Sarkaria S, Singh H, Slivka A, Nalesnik M, Han X, Nikiforova MN, Lawlor RT, Mafficini A, Rusev B, Corbo V, Luchini C, Bersani S, Pea A, Cingarlini S, Landoni L, Salvia R, Milione M, Milella M, Scarpa A, Hong SM, Heaphy CM, Singhi AD (2021) Non-functional pancreatic neuroendocrine tumours: ATRX\/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX\/PDX1 expression and tumour size. Gut. https:\/\/doi.org\/10.1136\/gutjnl-2020-322595.","journal-title":"Gut"},{"key":"9708_CR61","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/B978-0-12-820683-6.00006-3","volume":"181","author":"SL Asa","year":"2021","unstructured":"Asa SL, Ezzat S (2021) Hypothalamic hormone-producing tumors. Handb Clin Neurol 181: 67-74. https:\/\/doi.org\/10.1016\/B978-0-12-820683-6.00006-3.","journal-title":"Handb Clin Neurol"},{"key":"9708_CR62","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/his.13943","volume":"76","author":"AM Bellizzi","year":"2020","unstructured":"Bellizzi AM (2020) SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas. Histopathology 76: 251-264. https:\/\/doi.org\/10.1111\/his.13943.","journal-title":"Histopathology"},{"key":"9708_CR63","doi-asserted-by":"publisher","unstructured":"Moshiri AS, Doumani R, Yelistratova L, Blom A, Lachance K, Shinohara MM, Delaney M, Chang O, McArdle S, Thomas H, Asgari MM, Huang ML, Schwartz SM, Nghiem P (2017) Polyomavirus-Negative Merkel Cell Carcinoma: A More Aggressive Subtype Based on Analysis of 282 Cases Using Multimodal Tumor Virus Detection. J Invest Dermatol 137: 819\u2013827. S0022\u2013202X(16)32613\u20136 [pii];https:\/\/doi.org\/10.1016\/j.jid.2016.10.028.","DOI":"10.1016\/j.jid.2016.10.028"},{"key":"9708_CR64","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s12022-021-09678-x","volume":"32","author":"SL Asa","year":"2021","unstructured":"Asa SL (2021) Challenges in the Diagnosis of Pituitary Neuroendocrine Tumors. Endocr Pathol 32: 222-227. https:\/\/doi.org\/10.1007\/s12022-021-09678-x.","journal-title":"Endocr Pathol"},{"key":"9708_CR65","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12022-020-09611-8","volume":"31","author":"WM Hackeng","year":"2020","unstructured":"Hackeng WM, Schelhaas W, Morsink FHM, Heidsma CM, van ES, Valk GD, Vriens MR, Heaphy CM, Nieveen van Dijkum EJM, Offerhaus GJA, Dreijerink KMA, Brosens LAA (2020) Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas. Endocr Pathol 31: 108-118. https:\/\/doi.org\/10.1007\/s12022-020-09611-8.","journal-title":"Endocr Pathol"},{"key":"9708_CR66","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/PAS.0000000000000400","volume":"39","author":"JY Kim","year":"2015","unstructured":"Kim JY, Kim KS, Kim KJ, Park IJ, Lee JL, Myung SJ, Park Y, Park YS, Yu CS, Kim JC, Yu E, Jang HJ, Hong SM (2015) Non-L-cell immunophenotype and large tumor size in rectal neuroendocrine tumors are associated with aggressive clinical behavior and worse prognosis. Am J Surg Pathol 39: 632-643. https:\/\/doi.org\/10.1097\/PAS.0000000000000400.","journal-title":"Am J Surg Pathol"},{"key":"9708_CR67","doi-asserted-by":"publisher","first-page":"813","DOI":"10.4143\/crt.2014.238","volume":"47","author":"JH Sohn","year":"2015","unstructured":"Sohn JH, Cho MY, Park Y, Kim H, Kim WH, Kim JM, Jung ES, Kim KM, Lee JH, Chan HK, Park DY, Joo M, Kim S, Moon WS, Kang MS, Jin SY, Kang YK, Yoon SO, Han H, Choi E (2015) Prognostic Significance of Defining L-Cell Type on the Biologic Behavior of Rectal Neuroendocrine Tumors in Relation with Pathological Parameters. Cancer Res Treat 47: 813-822. https:\/\/doi.org\/10.4143\/crt.2014.238.","journal-title":"Cancer Res Treat"},{"key":"9708_CR68","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1097\/PAS.0b013e3182819f0f","volume":"37","author":"SH Lee","year":"2013","unstructured":"Lee SH, Kim BC, Chang HJ, Sohn DK, Han KS, Hong CW, Lee EJ, Lee JB, Lee DS, Lee IT, Youk EG (2013) Rectal neuroendocrine and L-cell tumors: diagnostic dilemma and therapeutic strategy. Am J Surg Pathol 37: 1044-1052. https:\/\/doi.org\/10.1097\/PAS.0b013e3182819f0f.","journal-title":"Am J Surg Pathol"},{"key":"9708_CR69","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1200\/JCO.21.01329","volume":"40","author":"B Xu","year":"2022","unstructured":"Xu B, Fuchs TL, Ahmadi S, Alghamdi M, Alzumaili B, Bani MA, Baudin E, Chou A, De LA, Fagin JA, Ganly I, Glover A, Hartl D, Kanaan C, Khneisser P, Najdawi F, Nigam A, Papachristos A, Repaci A, Spanheimer PM, Solaroli E, Untch BR, Barletta JA, Tallini G, Al GA, Gill AJ, Ghossein RA (2022) International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma. J Clin Oncol 40: 96-104. https:\/\/doi.org\/10.1200\/JCO.21.01329.","journal-title":"J Clin Oncol"},{"key":"9708_CR70","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s12022-020-09640-3","volume":"31","author":"S La Rosa","year":"2020","unstructured":"La Rosa S, Bonzini M, Sciarra A, Asioli S, Maragliano R, Arrigo M, Foschini MP, Righi A, Maletta F, Motolese A, Papotti M, Sessa F, Uccella S (2020) Exploring the Prognostic Role of Ki67 Proliferative Index in Merkel Cell Carcinoma of the Skin: Clinico-Pathologic Analysis of 84 Cases and Review of the Literature. Endocr Pathol 31: 392-400. https:\/\/doi.org\/10.1007\/s12022-020-09640-3.","journal-title":"Endocr Pathol"},{"key":"9708_CR71","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s12022-020-09660-z","volume":"32","author":"S Uccella","year":"2021","unstructured":"Uccella S, La Rosa S, Metovic J, Marchiori D, Scoazec JY, Volante M, Mete O, Papotti M (2021) Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites. Endocr Pathol 32: 192-210. https:\/\/doi.org\/10.1007\/s12022-020-09660-z.","journal-title":"Endocr Pathol"},{"key":"9708_CR72","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12022-020-09657-8","volume":"32","author":"C Liverani","year":"2021","unstructured":"Liverani C, Bongiovanni A, Mercatali L, Pieri F, Spadazzi C, Miserocchi G, Di MG, Foca F, Ravaioli S, De VA, Cocchi C, Rossi G, Recine F, Ibrahim T (2021) Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms. Endocr Pathol 32: 309-317. https:\/\/doi.org\/10.1007\/s12022-020-09657-8.","journal-title":"Endocr Pathol"},{"key":"9708_CR73","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12022-020-09649-8","volume":"32","author":"B Li","year":"2021","unstructured":"Li B, Li X, Mao R, Liu M, Fu L, Shi L, Zhao S, Fu M (2021) Overexpression of ODF1 in Gastrointestinal Tract Neuroendocrine Neoplasms: a Novel Potential Immunohistochemical Biomarker for Well-differentiated Neuroendocrine Tumors. Endocr Pathol 32: 301-308. https:\/\/doi.org\/10.1007\/s12022-020-09649-8.","journal-title":"Endocr Pathol"},{"key":"9708_CR74","doi-asserted-by":"publisher","unstructured":"Konukiewitz B, Jesinghaus M, Steiger K, Schlitter AM, Kasajima A, Sipos B, Zamboni G, Weichert W, Pfarr N, Kloppel G (2018) Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3. Hum Pathol 77: 70\u201379. S0046\u20138177(18)30095\u20139; https:\/\/doi.org\/10.1016\/j.humpath.2018.03.018.","DOI":"10.1016\/j.humpath.2018.03.018"},{"key":"9708_CR75","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-021-03202-6","author":"A Kasajima","year":"2021","unstructured":"Kasajima A, Konukiewitz B, Schlitter AM, Weichert W, Kloppel G (2021) An analysis of 130 neuroendocrine tumors G3 regarding prevalence, origin, metastasis, and diagnostic features. Virchows Arch. https:\/\/doi.org\/10.1007\/s00428-021-03202-6.","journal-title":"Virchows Arch"},{"key":"9708_CR76","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s12022-021-09662-5","volume":"32","author":"SL Asa","year":"2021","unstructured":"Asa SL, La Rosa S, Basturk O, Adsay V, Minnetti M, Grossman AB (2021) Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors. Endocr Pathol 32: 169-191. https:\/\/doi.org\/10.1007\/s12022-021-09662-5.","journal-title":"Endocr Pathol"},{"key":"9708_CR77","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s12022-021-09668-z","volume":"32","author":"M Volante","year":"2021","unstructured":"Volante M, Mete O, Pelosi G, Roden AC, Speel EJM, Uccella S (2021) Molecular Pathology of Well-Differentiated Pulmonary and Thymic Neuroendocrine Tumors: What Do Pathologists Need to Know? Endocr Pathol 32: 154-168. https:\/\/doi.org\/10.1007\/s12022-021-09668-z.","journal-title":"Endocr Pathol"},{"key":"9708_CR78","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/PAS.0b013e3182417d36","volume":"36","author":"S Yachida","year":"2012","unstructured":"Yachida S, Vakiani E, White CM, Zhong Y, Saunders T, Morgan R, de Wilde RF, Maitra A, Hicks J, Demarzo AM, Shi C, Sharma R, Laheru D, Edil BH, Wolfgang CL, Schulick RD, Hruban RH, Tang LH, Klimstra DS, Iacobuzio-Donahue CA (2012) Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol 36: 173-184. https:\/\/doi.org\/10.1097\/PAS.0b013e3182417d36.","journal-title":"Am J Surg Pathol"},{"key":"9708_CR79","doi-asserted-by":"publisher","unstructured":"Baine MK, Hsieh MS, Lai WV, Egger JV, Jungbluth AA, Daneshbod Y, Beras A, Spencer R, Lopardo J, Bodd F, Montecalvo J, Sauter JL, Chang JC, Buonocore DJ, Travis WD, Sen T, Poirier JT, Rudin CM, Rekhtman N (2020) SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization. J Thorac Oncol 15: 1823\u20131835. S1556\u20130864(20)30755\u20133; https:\/\/doi.org\/10.1016\/j.jtho.2020.09.009.","DOI":"10.1016\/j.jtho.2020.09.009"},{"key":"9708_CR80","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41568-019-0133-9","volume":"19","author":"CM Rudin","year":"2019","unstructured":"Rudin CM, Poirier JT, Byers LA, Dive C, Dowlati A, George J, Heymach JV, Johnson JE, Lehman JM, MacPherson D, Massion PP, Minna JD, Oliver TG, Quaranta V, Sage J, Thomas RK, Vakoc CR, Gazdar AF (2019) Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nat Rev Cancer 19: 289-297. https:\/\/doi.org\/10.1038\/s41568-019-0133-9.","journal-title":"Nat Rev Cancer"},{"key":"9708_CR81","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.1038\/s41467-021-26042-z","volume":"12","author":"P Cejas","year":"2021","unstructured":"Cejas P, Xie Y, Font-Tello A, Lim K, Syamala S, Qiu X, Tewari AK, Shah N, Nguyen HM, Patel RA, Brown L, Coleman I, Hackeng WM, Brosens L, Dreijerink KMA, Ellis L, Alaiwi SA, Seo JH, Baca S, Beltran H, Khani F, Pomerantz M, Dall'Agnese A, Crowdis J, Van Allen EM, Bellmunt J, Morrisey C, Nelson PS, DeCaprio J, Farago A, Dyson N, Drapkin B, Liu XS, Freedman M, Haffner MC, Corey E, Brown M, Long HW (2021) Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer. Nat Commun 12: 5775. https:\/\/doi.org\/10.1038\/s41467-021-26042-z.","journal-title":"Nat Commun"},{"key":"9708_CR82","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1038\/s41467-018-06498-2","volume":"9","author":"CS Chan","year":"2018","unstructured":"Chan CS, Laddha SV, Lewis PW, Koletsky MS, Robzyk K, Da SE, Torres PJ, Untch BR, Li J, Bose P, Chan TA, Klimstra DS, Allis CD, Tang LH (2018) ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup. Nat Commun 9: 4158. https:\/\/doi.org\/10.1038\/s41467-018-06498-2.","journal-title":"Nat Commun"},{"key":"9708_CR83","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/s41591-019-0493-4","volume":"25","author":"P Cejas","year":"2019","unstructured":"Cejas P, Drier Y, Dreijerink KMA, Brosens LAA, Deshpande V, Epstein CB, Conemans EB, Morsink FHM, Graham MK, Valk GD, Vriens MR, Castillo CF, Ferrone CR, Adar T, Bowden M, Whitton HJ, Da SA, Font-Tello A, Long HW, Gaskell E, Shoresh N, Heaphy CM, Sicinska E, Kulke MH, Chung DC, Bernstein BE, Shivdasani RA (2019) Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors. Nat Med 25: 1260-1265. https:\/\/doi.org\/10.1038\/s41591-019-0493-4.","journal-title":"Nat Med"},{"key":"9708_CR84","doi-asserted-by":"publisher","unstructured":"Boons\u00a0G, Vandamme\u00a0T, Ibrahim\u00a0J, Roeyen\u00a0G, Driessen\u00a0A, Peeters\u00a0D, Lawrence\u00a0B, Print\u00a0C, Peeters\u00a0M, Van\u00a0CG, Op de\u00a0BK (2020) PDX1 DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different Prognosis Cancers (Basel) 12.\u00a0https:\/\/doi.org\/10.3390\/cancers12061461","DOI":"10.3390\/cancers12061461"},{"key":"9708_CR85","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s42003-020-01479-y","volume":"3","author":"A Di Domenico","year":"2020","unstructured":"Di Domenico A, Pipinikas CP, Maire RS, Brautigam K, Simillion C, Dettmer MS, Vassella E, Thirlwell C, Perren A, Marinoni I (2020) Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression. Commun Biol 3: 740. https:\/\/doi.org\/10.1038\/s42003-020-01479-y.","journal-title":"Commun Biol"},{"key":"9708_CR86","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/path.5834","volume":"256","author":"KM Dreijerink","year":"2022","unstructured":"Dreijerink KM, Hackeng WM, Singhi AD, Heaphy CM, Brosens LA (2022) Clinical implications of cell-of-origin epigenetic characteristics in non-functional pancreatic neuroendocrine tumors. J Pathol 256: 143-148. https:\/\/doi.org\/10.1002\/path.5834.","journal-title":"J Pathol"},{"key":"9708_CR87","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1136\/gutjnl-2018-317233","volume":"69","author":"X Hong","year":"2020","unstructured":"Hong X, Qiao S, Li F, Wang W, Jiang R, Wu H, Chen H, Liu L, Peng J, Wang J, Jia C, Liang X, Dai H, Jiang J, Zhang T, Liao Q, Dai M, Cong L, Han X, Guo D, Liang Z, Li D, Zheng Z, Ye C, Li S, Zhao Y, Wu K, Wu W (2020) Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system. Gut 69: 877-887. https:\/\/doi.org\/10.1136\/gutjnl-2018-317233.","journal-title":"Gut"},{"key":"9708_CR88","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11154-017-9428-x","volume":"18","author":"F Inzani","year":"2017","unstructured":"Inzani F, Petrone G, Fadda G, Rindi G (2017) Cyto-histology in NET: what is necessary today and what is the future? Rev Endocr Metab Disord 18: 381-391. https:\/\/doi.org\/10.1007\/s11154-017-9428-x.","journal-title":"Rev Endocr Metab Disord"},{"key":"9708_CR89","doi-asserted-by":"publisher","unstructured":"Tang LH, Klimstra DS (2011) Conundrums and Caveats in Neuroendocrine Tumors of the Pancreas. Surg Pathol Clin 4: 589\u2013624. S1875\u20139181(11)00095-X; https:\/\/doi.org\/10.1016\/j.path.2011.03.003.","DOI":"10.1016\/j.path.2011.03.003"},{"key":"9708_CR90","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2019-0654-RA","author":"LH Tang","year":"2020","unstructured":"Tang LH (2020) Pancreatic Neuroendocrine Neoplasms: Landscape and Horizon. Arch Pathol Lab Med . https:\/\/doi.org\/10.5858\/arpa.2019-0654-RA.","journal-title":"Arch Pathol Lab Med"},{"key":"9708_CR91","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/PAS.0000000000000169","volume":"38","author":"O Basturk","year":"2014","unstructured":"Basturk O, Tang L, Hruban RH, Adsay V, Yang Z, Krasinskas AM, Vakiani E, La Rosa S, Jang KT, Frankel WL, Liu X, Zhang L, Giordano TJ, Bellizzi AM, Chen JH, Shi C, Allen P, Reidy DL, Wolfgang CL, Saka B, Rezaee N, Deshpande V, Klimstra DS (2014) Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases. Am J Surg Pathol 38: 437-447. https:\/\/doi.org\/10.1097\/PAS.0000000000000169.","journal-title":"Am J Surg Pathol"},{"key":"9708_CR92","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s12022-020-09646-x","volume":"31","author":"O Mete","year":"2020","unstructured":"Mete O, Asa SL (2020) Structure, Function, and Morphology in the Classification of Pituitary Neuroendocrine Tumors: the Importance of Routine Analysis of Pituitary Transcription Factors. Endocr Pathol 31: 330-336. https:\/\/doi.org\/10.1007\/s12022-020-09646-x.","journal-title":"Endocr Pathol"},{"key":"9708_CR93","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41379-018-0016-8","volume":"31","author":"O Mete","year":"2018","unstructured":"Mete O, Cintosun A, Pressman I, Asa SL (2018) Epidemiology and biomarker profile of pituitary adenohypophysial tumors. Mod Pathol 31: 900-909. https:\/\/doi.org\/10.1038\/s41379-018-0016-8.","journal-title":"Mod Pathol"},{"issue":"Suppl 1","key":"9708_CR94","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5146\/tjpath.2015.01311","volume":"31","author":"K Gomez-Hernandez","year":"2015","unstructured":"Gomez-Hernandez K, Ezzat S, Asa SL, Mete O (2015) Clinical Implications of Accurate Subtyping of Pituitary Adenomas: Perspectives from the Treating Physician. Turk Patoloji Derg 31 Suppl 1: 4-17. https:\/\/doi.org\/10.5146\/tjpath.2015.01311.","journal-title":"Turk Patoloji Derg"},{"key":"9708_CR95","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/j.semdp.2013.06.002","volume":"30","author":"O Mete","year":"2013","unstructured":"Mete O, Asa SL (2013) Therapeutic implications of accurate classification of pituitary adenomas. Semin Diagn Pathol 30: 158-164.","journal-title":"Semin Diagn Pathol"},{"key":"9708_CR96","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1158\/1078-0432.CCR-15-2946","volume":"22","author":"N Rekhtman","year":"2016","unstructured":"Rekhtman N, Pietanza MC, Hellmann MD, Naidoo J, Arora A, Won H, Halpenny DF, Wang H, Tian SK, Litvak AM, Paik PK, Drilon AE, Socci N, Poirier JT, Shen R, Berger MF, Moreira AL, Travis WD, Rudin CM, Ladanyi M (2016) Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets. Clin Cancer Res 22: 3618-3629. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2946.","journal-title":"Clin Cancer Res"},{"key":"9708_CR97","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/PAS.0000000000000767","volume":"41","author":"AM Quinn","year":"2017","unstructured":"Quinn AM, Chaturvedi A, Nonaka D (2017) High-grade Neuroendocrine Carcinoma of the Lung With Carcinoid Morphology: A Study of 12 Cases. Am J Surg Pathol 41: 263-270. https:\/\/doi.org\/10.1097\/PAS.0000000000000767.","journal-title":"Am J Surg Pathol"},{"key":"9708_CR98","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00428-017-2177-0","volume":"471","author":"C Marchio","year":"2017","unstructured":"Marchio C, Gatti G, Massa F, Bertero L, Filosso P, Pelosi G, Cassoni P, Volante M, Papotti M (2017) Distinctive pathological and clinical features of lung carcinoids with high proliferation index. Virchows Arch 471: 713-720. https:\/\/doi.org\/10.1007\/s00428-017-2177-0.","journal-title":"Virchows Arch"},{"key":"9708_CR99","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000495806","volume":"108","author":"A Kasajima","year":"2019","unstructured":"Kasajima A, Konukiewitz B, Oka N, Suzuki H, Sakurada A, Okada Y, Kameya T, Ishikawa Y, Sasano H, Weichert W, Kloppel G (2019) Clinicopathological Profiling of Lung Carcinoids with a Ki67 Index > 20. Neuroendocrinology 108: 109-120. https:\/\/doi.org\/10.1159\/000495806.","journal-title":"Neuroendocrinology"},{"key":"9708_CR100","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-021-09693-y","author":"W Saeger","year":"2021","unstructured":"Saeger W, Mawrin C, Meinhardt M, Wefers AK, Jacobsen F (2021) Two Pituitary Neuroendocrine Tumors (PitNETs) with Very High Proliferation and TP53 Mutation - High-Grade PitNET or PitNEC? Endocr Pathol . https:\/\/doi.org\/10.1007\/s12022-021-09693-y.","journal-title":"Endocr Pathol"},{"key":"9708_CR101","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3904\/kjim.2011.26.1.103","volume":"26","author":"JA Kim","year":"2011","unstructured":"Kim JA, Choi WH, Kim CN, Moon YS, Chang SH, Lee HR (2011) Duodenal somatostatinoma: a case report and review. Korean J Intern Med 26: 103-107. https:\/\/doi.org\/10.3904\/kjim.2011.26.1.103.","journal-title":"Korean J Intern Med"},{"key":"9708_CR102","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s12022-021-09684-z","volume":"32","author":"SL Asa","year":"2021","unstructured":"Asa SL, Arkun K, Tischler AS, Qamar A, Deng FM, Perez-Ordonez B, Weinreb I, Bishop JA, Wenig BM, Mete O (2021) Middle Ear \u201cAdenoma\u201d: a Neuroendocrine Tumor with Predominant L Cell Differentiation. Endocr Pathol 32: 433-441. https:\/\/doi.org\/10.1007\/s12022-021-09684-z.","journal-title":"Endocr Pathol"},{"key":"9708_CR103","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/PAS.0b013e31824aba59","volume":"36","author":"ES Chan","year":"2012","unstructured":"Chan ES, Alexander J, Swanson PE, Jain D, Yeh MM (2012) PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms. Am J Surg Pathol 36: 737-743. https:\/\/doi.org\/10.1097\/PAS.0b013e31824aba59.","journal-title":"Am J Surg Pathol"},{"key":"9708_CR104","doi-asserted-by":"publisher","unstructured":"Singh S, Asa SL, Dey C, Kennecke H, Laidley D, Law C, Asmis T, Chan D, Ezzat S, Goodwin R, Mete O, Pasieka J, Rivera J, Wong R, Segelov E, Rayson D (2016) Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus. Cancer Treat Rev 47: 32\u201345. S0305\u20137372(16)30021\u20134.\u00a0https:\/\/doi.org\/10.1016\/j.ctrv.2016.05.003.","DOI":"10.1016\/j.ctrv.2016.05.003"},{"key":"9708_CR105","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1097\/PAS.00000000000009","volume":"41","author":"LM Rooper","year":"2017","unstructured":"Rooper LM, Sharma R, Li QK, Illei PB, Westra WH (2017) INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity. Am J Surg Pathol 41: 1561-1569. https:\/\/doi.org\/10.1097\/PAS.00000000000009.","journal-title":"Am J Surg Pathol"},{"key":"9708_CR106","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/PAS.0000000000001037","volume":"42","author":"LM Rooper","year":"2018","unstructured":"Rooper LM, Bishop JA, Westra WH (2018) INSM1 is a Sensitive and Specific Marker of Neuroendocrine Differentiation in Head and Neck Tumors. Am J Surg Pathol 42: 665-671. https:\/\/doi.org\/10.1097\/PAS.0000000000001037.","journal-title":"Am J Surg Pathol"},{"key":"9708_CR107","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/PAI.0000000000000824","volume":"28","author":"IE Kim Jr","year":"2020","unstructured":"Kim IE, Jr., Amin A, Wang LJ, Cheng L, Perrino CM (2020) Insulinoma-associated Protein 1 (INSM1) Expression in Small Cell Neuroendocrine Carcinoma of the Urinary Tract. Appl Immunohistochem Mol Morphol 28: 687-693. https:\/\/doi.org\/10.1097\/PAI.0000000000000824.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"9708_CR108","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s12022-020-09645-y","volume":"31","author":"CC Juhlin","year":"2020","unstructured":"Juhlin CC, Zedenius J, Hoog A (2020) Clinical Routine Application of the Second-generation Neuroendocrine Markers ISL1, INSM1, and Secretagogin in Neuroendocrine Neoplasia: Staining Outcomes and Potential Clues for Determining Tumor Origin. Endocr Pathol 31: 401-410. https:\/\/doi.org\/10.1007\/s12022-020-09645-y.","journal-title":"Endocr Pathol"},{"key":"9708_CR109","doi-asserted-by":"publisher","unstructured":"Kovari\u00a0B, Turkevi-Nagy\u00a0S, Bathori\u00a0A, Fekete\u00a0Z, Krenacs\u00a0L (2020) Syntaxin 1: A Novel Robust Immunophenotypic Marker of Neuroendocrine Tumors Int J Mol Sci 21.https:\/\/doi.org\/10.3390\/ijms21041213","DOI":"10.3390\/ijms21041213"},{"key":"9708_CR110","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/his.14178","volume":"77","author":"S Uccella","year":"2020","unstructured":"Uccella S, La Rosa S (2020) Looking into digestive mixed neuroendocrine - nonneuroendocrine neoplasms: subtypes, prognosis, and predictive factors. Histopathology 77: 700-717. https:\/\/doi.org\/10.1111\/his.14178.","journal-title":"Histopathology"},{"key":"9708_CR111","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1097\/PAS.0000000000000662","volume":"40","author":"LH Tang","year":"2016","unstructured":"Tang LH, Basturk O, Sue JJ, Klimstra DS (2016) A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas. Am J Surg Pathol 40: 1192-1202. https:\/\/doi.org\/10.1097\/PAS.0000000000000662.","journal-title":"Am J Surg Pathol"},{"key":"9708_CR112","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-021-09689-8","author":"R Maragliano","year":"2021","unstructured":"Maragliano R, Libera L, Carnevali I, Pensotti V, De VG, Testa M, Amaglio C, Leoni E, Formenti G, Sessa F, Furlan D, Uccella S (2021) Mixed Neuroendocrine\/Non-neuroendocrine Neoplasm (MiNEN) of the Ovary Arising from Endometriosis: Molecular Pathology Analysis in Support of a Pathogenetic Paradigm. Endocr Pathol. https:\/\/doi.org\/10.1007\/s12022-021-09689-8.","journal-title":"Endocr Pathol"},{"key":"9708_CR113","unstructured":"Uccella S, Ottini G, Facco C, Maragliano R, Asioli S, Sessa F, La Rosa S (2017) Neuroendocrine neoplasms of the head and neck and olfactory neuroblastoma. Diagnosis and classification. Pathologica 109: 14\u201330. Pacini."},{"key":"9708_CR114","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1309\/AJCPGA0IUA8BHQEZ","volume":"142","author":"C Zhang","year":"2014","unstructured":"Zhang C, Schmidt LA, Hatanaka K, Thomas D, Lagstein A, Myers JL (2014) Evaluation of napsin A, TTF-1, p63, p40, and CK5\/6 immunohistochemical stains in pulmonary neuroendocrine tumors. Am J Clin Pathol 142: 320-324. https:\/\/doi.org\/10.1309\/AJCPGA0IUA8BHQEZ.","journal-title":"Am J Clin Pathol"},{"key":"9708_CR115","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s12105-017-0825-y","volume":"12","author":"JS Lewis Jr","year":"2018","unstructured":"Lewis JS, Jr., Chernock RD, Bishop JA (2018) Squamous and Neuroendocrine Specific Immunohistochemical Markers in Head and Neck Squamous Cell Carcinoma: A Tissue Microarray Study. Head Neck Pathol 12: 62-70. https:\/\/doi.org\/10.1007\/s12105-017-0825-y.","journal-title":"Head Neck Pathol"},{"key":"9708_CR116","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41379-018-0155-y","volume":"32","author":"T Kervarrec","year":"2019","unstructured":"Kervarrec T, Tallet A, Miquelestorena-Standley E, Houben R, Schrama D, Gambichler T, Berthon P, Le CY, Hainaut-Wierzbicka E, Aubin F, Bens G, Tabareau-Delalande F, Beneton N, Fromont G, Arbion F, Leteurtre E, Touze A, Samimi M, Guyetant S (2019) Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomas. Mod Pathol 32: 499-510. https:\/\/doi.org\/10.1038\/s41379-018-0155-y.","journal-title":"Mod Pathol"},{"key":"9708_CR117","doi-asserted-by":"publisher","unstructured":"Inzani F, Petrone G, Rindi G (2018) The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia. Endocrinol Metab Clin North Am 47: 463\u2013470. S0889\u20138529(18)30520\u20136; https:\/\/doi.org\/10.1016\/j.ecl.2018.04.008.","DOI":"10.1016\/j.ecl.2018.04.008"},{"key":"9708_CR118","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12022-020-09628-z","volume":"31","author":"Y Xue","year":"2020","unstructured":"Xue Y, Reid MD, Pehlivanoglu B, Obeng RC, Jiang H, Memis B, Lui SK, Sarmiento J, Kooby D, Maithel SK, El-Rayes B, Basturk O, Adsay V (2020) Morphologic Variants of Pancreatic Neuroendocrine Tumors: Clinicopathologic Analysis and Prognostic Stratification. Endocr Pathol 31: 239-253. https:\/\/doi.org\/10.1007\/s12022-020-09628-z.","journal-title":"Endocr Pathol"},{"key":"9708_CR119","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/PAS.0000000000000408","volume":"39","author":"O Basturk","year":"2015","unstructured":"Basturk O, Yang Z, Tang LH, Hruban RH, Adsay V, McCall CM, Krasinskas AM, Jang KT, Frankel WL, Balci S, Sigel C, Klimstra DS (2015) The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms. Am J Surg Pathol 39: 683-690. https:\/\/doi.org\/10.1097\/PAS.0000000000000408.","journal-title":"Am J Surg Pathol"},{"key":"9708_CR120","doi-asserted-by":"publisher","unstructured":"Dinter H, Bohnenberger H, Beck J, Bornemann-Kolatzki K, Schutz E, Kuffer S, Klein L, Franks TJ, Roden A, Emmert A, Hinterthaner M, Marino M, Brcic L, Popper H, Weis CA, Pelosi G, Marx A, Strobel P (2019) Molecular Classification of Neuroendocrine Tumors of the Thymus. J Thorac Oncol 14: 1472\u20131483. S1556\u20130864(19)30312\u20130; https:\/\/doi.org\/10.1016\/j.jtho.2019.04.015.","DOI":"10.1016\/j.jtho.2019.04.015"},{"key":"9708_CR121","doi-asserted-by":"crossref","unstructured":"Tang LH, Untch BR, Reidy DL, O'Reilly E, Dhall D, Jih L, Basturk O, Allen PJ, Klimstra DS (2016) Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas. Clin Cancer Res 22: 1011\u20131017. 1078\u20130432.CCR-15\u20130548.","DOI":"10.1158\/1078-0432.CCR-15-0548"},{"key":"9708_CR122","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s12022-021-09676-z","volume":"32","author":"S La Rosa","year":"2021","unstructured":"La Rosa S (2021) Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine\/Non-neuroendocrine Neoplasms. Endocr Pathol 32: 245-257. https:\/\/doi.org\/10.1007\/s12022-021-09676-z.","journal-title":"Endocr Pathol"},{"key":"9708_CR123","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature14664","volume":"524","author":"J George","year":"2015","unstructured":"George J, Lim JS, Jang SJ, Cun Y, Ozretic L, Kong G, Leenders F, Lu X, Fernandez-Cuesta L, Bosco G, Muller C, Dahmen I, Jahchan NS, Park KS, Yang D, Karnezis AN, Vaka D, Torres A, Wang MS, Korbel JO, Menon R, Chun SM, Kim D, Wilkerson M, Hayes N, Engelmann D, Putzer B, Bos M, Michels S, Vlasic I, Seidel D, Pinther B, Schaub P, Becker C, Altmuller J, Yokota J, Kohno T, Iwakawa R, Tsuta K, Noguchi M, Muley T, Hoffmann H, Schnabel PA, Petersen I, Chen Y, Soltermann A, Tischler V, Choi CM, Kim YH, Massion PP, Zou Y, Jovanovic D, Kontic M, Wright GM, Russell PA, Solomon B, Koch I, Lindner M, Muscarella LA, la TA, Field JK, Jakopovic M, Knezevic J, Castanos-Velez E, Roz L, Pastorino U, Brustugun OT, Lund-Iversen M, Thunnissen E, Kohler J, Schuler M, Botling J, Sandelin M, Sanchez-Cespedes M, Salvesen HB, Achter V, Lang U, Bogus M, Schneider PM, Zander T, Ansen S, Hallek M, Wolf J, Vingron M, Yatabe Y, Travis WD, Nurnberg P, Reinhardt C, Perner S, Heukamp L, Buttner R, Haas SA, Brambilla E, Peifer M, Sage J, Thomas RK (2015) Comprehensive genomic profiles of small cell lung cancer. Nature 524: 47-53. https:\/\/doi.org\/10.1038\/nature14664.","journal-title":"Nature"},{"key":"9708_CR124","doi-asserted-by":"publisher","unstructured":"Takizawa N, Ohishi Y, Hirahashi M, Takahashi S, Nakamura K, Tanaka M, Oki E, Takayanagi R, Oda Y (2015) Molecular characteristics of colorectal neuroendocrine carcinoma; similarities with adenocarcinoma rather than neuroendocrine tumor. Hum Pathol 46: 1890\u20131900. S0046\u20138177(15)00310-X; https:\/\/doi.org\/10.1016\/j.humpath.2015.08.006.","DOI":"10.1016\/j.humpath.2015.08.006"},{"key":"9708_CR125","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s12022-016-9432-9","volume":"27","author":"S La Rosa","year":"2016","unstructured":"La Rosa S, Sessa F, Uccella S (2016) Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms. Endocr Pathol 27: 284-311. https:\/\/doi.org\/10.1007\/s12022-016-9432-9.","journal-title":"Endocr Pathol"},{"key":"9708_CR126","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1530\/ERC-17-0557","volume":"25","author":"M Milione","year":"2018","unstructured":"Milione M, Maisonneuve P, Pellegrinelli A, Grillo F, Albarello L, Spaggiari P, Vanoli A, Tagliabue G, Pisa E, Messerini L, Centonze G, Inzani F, Scarpa A, Papotti M, Volante M, Sessa F, Fazio N, Pruneri G, Rindi G, Solcia E, La Rosa S, Capella C (2018) Ki67 proliferative index of the neuroendocrine component drives MANEC prognosis. Endocr Relat Cancer 25: 583-593. https:\/\/doi.org\/10.1530\/ERC-17-0557.","journal-title":"Endocr Relat Cancer"},{"key":"9708_CR127","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1159\/000508376","volume":"111","author":"M Milione","year":"2021","unstructured":"Milione M, Maisonneuve P, Grillo F, Mangogna A, Centonze G, Prinzi N, Pusceddu S, Garzone G, Cattaneo L, Busico A, Bossi P, Spaggiari P, Pellegrinelli A, Del GA, Ferrero S, Kankava K, Pruneri G, Rolli L, Roca E, Bercich L, Tironi A, Benvenuti MR, Gallazzi MS, Romano R, Berruti A, Pastorino U, Capella C (2021) Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis. Neuroendocrinology 111: 475-489. https:\/\/doi.org\/10.1159\/000508376.","journal-title":"Neuroendocrinology"},{"key":"9708_CR128","doi-asserted-by":"publisher","unstructured":"Horn LC, Hentschel B, Bilek K, Richter CE, Einenkel J, Leo C (2006) Mixed small cell carcinomas of the uterine cervix: prognostic impact of focal neuroendocrine differentiation but not of Ki-67 labeling index. Ann Diagn Pathol 10: 140\u2013143. S1092\u20139134(05)00125\u20135; https:\/\/doi.org\/10.1016\/j.anndiagpath.2005.07.019 .","DOI":"10.1016\/j.anndiagpath.2005.07.019"},{"key":"9708_CR129","doi-asserted-by":"publisher","unstructured":"Frizziero\u00a0M, Chakrabarty\u00a0B, Nagy\u00a0B, Lamarca\u00a0A, Hubner\u00a0RA, Valle\u00a0JW, McNamara\u00a0MG (2020) Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Systematic Review of a Controversial and Underestimated Diagnosis J Clin Med 9.https:\/\/doi.org\/10.3390\/jcm9010273","DOI":"10.3390\/jcm9010273"},{"key":"9708_CR130","unstructured":"Cordier R (1924) Les cellules argentaffines dans les tumeurs intestinales. Arch Int Med Exp 5."},{"issue":"Suppl 1","key":"9708_CR131","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/00000478-198700111-00007","volume":"11","author":"K Lewin","year":"1987","unstructured":"Lewin K (1987) Carcinoid tumors and the mixed (composite) glandular-endocrine cell carcinomas. Am J Surg Pathol 11 Suppl 1: 71-86. https:\/\/doi.org\/10.1097\/00000478-198700111-00007.","journal-title":"Am J Surg Pathol"},{"key":"9708_CR132","first-page":"91","volume":"17","author":"C Capella","year":"2000","unstructured":"Capella C, La Rosa S, Uccella S, Billo P, Cornaggia M (2000) Mixed endocrine-exocrine tumors of the gastrointestinal tract. Semin Diagn Pathol 17: 91-103.","journal-title":"Semin Diagn Pathol"},{"key":"9708_CR133","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/cancers4010011","volume":"4","author":"S La Rosa","year":"2012","unstructured":"La Rosa S, Marando A, Sessa F, Capella C (2012) Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: An Update. Cancers (Basel) 4: 11-30. https:\/\/doi.org\/10.3390\/cancers4010011.","journal-title":"Cancers (Basel)"},{"key":"9708_CR134","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1159\/000475527","volume":"105","author":"de ML, Cros J, Neuzillet C, Hentic","year":"2017","unstructured":"de ML, Cros J, Neuzillet C, Hentic O, Egal A, Muller N, Bouche O, Cadiot G, Ruszniewski P, Couvelard A, Hammel P (2017) Digestive System Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms. Neuroendocrinology 105: 412-425. https:\/\/doi.org\/10.1159\/000475527.","journal-title":"Neuroendocrinology"},{"key":"9708_CR135","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1002\/1097-0142(19851201)56.112683\/aid-cncr28205611273.0.co2-l","volume":"56","author":"G Chejfec","year":"1985","unstructured":"Chejfec G, Capella C, Solcia E, Jao W, Gould VE (1985) Amphicrine cells, dysplasias, and neoplasias. Cancer 56: 2683-2690. https:\/\/doi.org\/10.1002\/1097-0142(19851201)56.112683\/aid-cncr28205611273.0.co2-l.","journal-title":"Cancer"},{"key":"9708_CR136","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/paor.1999.0211","volume":"5","author":"L Mandoky","year":"1999","unstructured":"Mandoky L (1999) Amphicrine tumor. Pathol Oncol Res 5: 239-244. https:\/\/doi.org\/10.1053\/paor.1999.0211.","journal-title":"Pathol Oncol Res"},{"key":"9708_CR137","doi-asserted-by":"publisher","unstructured":"Bellur S, van der Kwast T, Mete O (2019) Evolving concepts in prostatic neuroendocrine manifestations: from focal divergent differentiation to amphicrine carcinoma. Hum Pathol 85: 313\u2013327. S0046\u20138177(18)30468\u20134, https:\/\/doi.org\/10.1016\/j.humpath.2018.11.016.","DOI":"10.1016\/j.humpath.2018.11.016"},{"key":"9708_CR138","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12935-019-1031-7","volume":"19","author":"D Huang","year":"2019","unstructured":"Huang D, Ren F, Ni S, Tan C, Weng W, Zhang M, Xu M, Wang L, Xu Q, Sheng W (2019) Amphicrine carcinoma of the stomach and intestine: a clinicopathologic and pan-cancer transcriptome analysis of a distinct entity. Cancer Cell Int 19: 310. https:\/\/doi.org\/10.1186\/s12935-019-1031-7.","journal-title":"Cancer Cell Int"},{"key":"9708_CR139","unstructured":"(2017) TNM Classification of Malignant Tumours. Oxford: Wiley Blackwell."},{"key":"9708_CR140","doi-asserted-by":"publisher","unstructured":"O Casar-Borota HB Boldt BE Engstrom MS Andersen B Baussart D Bengtsson K Berinder B Ekman U Feldt-Rasmussen C Hoybye JOL Jorgensen AJ Kolnes M Korbonits AK Rasmussen JR Lindsay PB Loughrey D Maiter E Manojlovic-Gacic J Pahnke PL Poliani V Popovic O Ragnarsson C Schalin-Jantti D Scheie M Toth C Villa M Wirenfeldt J Kunicki P Burman 2020 Corticotroph aggressive pituitary tumours and carcinomas frequently harbour ATRX mutations J Clin Endocrinol Metab. 5940659https:\/\/doi.org\/10.1210\/clinem\/dgaa749","DOI":"10.1210\/clinem\/dgaa749"},{"key":"9708_CR141","doi-asserted-by":"publisher","unstructured":"Luchini C, Pelosi G, Scarpa A, Mattiolo P, Marchiori D, Maragliano R, Sessa F, Uccella S (2021) Neuroendocrine neoplasms of the biliary tree, liver and pancreas: a pathological approach. Pathologica 113: 28\u201338. https:\/\/doi.org\/10.32074\/1591-951X-231.","DOI":"10.32074\/1591-951X-231"},{"key":"9708_CR142","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12022-019-9572-9","volume":"30","author":"A Hodgson","year":"2019","unstructured":"Hodgson A, Pakbaz S, Tayyari F, Young JEM, Mete O (2019) Diagnostic Pitfall: Parathyroid Carcinoma Expands the Spectrum of Calcitonin and Calcitonin Gene-Related Peptide Expressing Neuroendocrine Neoplasms. Endocr Pathol 30: 168-172. https:\/\/doi.org\/10.1007\/s12022-019-9572-9.","journal-title":"Endocr Pathol"},{"key":"9708_CR143","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1530\/EJE-15-0917","volume":"174","author":"C Nozieres","year":"2016","unstructured":"Nozieres C, Chardon L, Goichot B, Borson-Chazot F, Hervieu V, Chikh K, Lombard-Bohas C, Walter T (2016) Neuroendocrine tumors producing calcitonin: characteristics, prognosis and potential interest of calcitonin monitoring during follow-up. Eur J Endocrinol 174: 335-341. https:\/\/doi.org\/10.1530\/EJE-15-0917.","journal-title":"Eur J Endocrinol"},{"key":"9708_CR144","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/modpathol.2016.69","volume":"29","author":"SK Mohanty","year":"2016","unstructured":"Mohanty SK, Kim SA, DeLair DF, Bose S, Laury AR, Chopra S, Mertens RB, Dhall D (2016) Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation. Mod Pathol 29: 788-798. https:\/\/doi.org\/10.1038\/modpathol.2016.69.","journal-title":"Mod Pathol"},{"key":"9708_CR145","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/PAT.0b013e32835f45c5","volume":"45","author":"O Mete","year":"2013","unstructured":"Mete O, Asa SL (2013) Precursor lesions of endocrine system neoplasms. Pathol 45: 316-330.","journal-title":"Pathol"},{"key":"9708_CR146","doi-asserted-by":"publisher","unstructured":"Klimstra DS, Adsay V (2016) Acinar neoplasms of the pancreas-A summary of 25 years of research. Semin Diagn Pathol 33: 307\u2013318. S0740\u20132570(16)30037\u20135; https:\/\/doi.org\/10.1053\/j.semdp.2016.05.009.","DOI":"10.1053\/j.semdp.2016.05.009"},{"key":"9708_CR147","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1440-1746.2010.06466.x","volume":"26","author":"NQ Nguyen","year":"2011","unstructured":"Nguyen NQ, Johns AL, Gill AJ, Ring N, Chang DK, Clarkson A, Merrett ND, Kench JG, Colvin EK, Scarlett CJ, Biankin AV (2011) Clinical and immunohistochemical features of 34 solid pseudopapillary tumors of the pancreas. J Gastroenterol Hepatol 26: 267-274. https:\/\/doi.org\/10.1111\/j.1440-1746.2010.06466.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"9708_CR148","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1097\/PAI.0000000000000601","volume":"28","author":"D Creytens","year":"2020","unstructured":"Creytens D (2020) SATB2 and TLE1 Expression in BCOR-CCNB3 (Ewing-like) Sarcoma, Mimicking Small Cell Osteosarcoma and Poorly Differentiated Synovial Sarcoma. Appl Immunohistochem Mol Morphol 28: e10-e12. https:\/\/doi.org\/10.1097\/PAI.0000000000000601.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"9708_CR149","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/PAS.0b013e31826d2639","volume":"37","author":"Q Huang","year":"2013","unstructured":"Huang Q, Wu H, Nie L, Shi J, Lebenthal A, Chen J, Sun Q, Yang J, Huang L, Ye Q (2013) Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases. Am J Surg Pathol 37: 467-483. https:\/\/doi.org\/10.1097\/PAS.0b013e31826d2639.","journal-title":"Am J Surg Pathol"},{"key":"9708_CR150","doi-asserted-by":"publisher","unstructured":"Rekhtman N, Montecalvo J, Chang JC, Alex D, Ptashkin RN, Ai N, Sauter JL, Kezlarian B, Jungbluth A, Desmeules P, Beras A, Bishop JA, Plodkowski AJ, Gounder MM, Schoenfeld AJ, Namakydoust A, Li BT, Rudin CM, Riely GJ, Jones DR, Ladanyi M, Travis WD (2020) SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas. J Thorac Oncol 15: 231\u2013247. S1556\u20130864(19)33643\u20133 ;https:\/\/doi.org\/10.1016\/j.jtho.2019.10.023.","DOI":"10.1016\/j.jtho.2019.10.023"},{"key":"9708_CR151","doi-asserted-by":"publisher","unstructured":"Auguste\u00a0A, Blanc-Durand\u00a0F, Deloger\u00a0M, Le\u00a0FA, Bareja\u00a0R, Wilkes\u00a0DC, Richon\u00a0C, Brunn\u00a0B, Caron\u00a0O, Devouassoux-Shisheboran\u00a0M, Gouy\u00a0S, Morice\u00a0P, Bentivegna\u00a0E, Sboner A, Elemento O, Rubin\u00a0MA, Pautier\u00a0P, Genestie\u00a0C, Cyrta\u00a0J, Leary A (2020) Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis Cells 9.https:\/\/doi.org\/10.3390\/cells9061496","DOI":"10.3390\/cells9061496"},{"key":"9708_CR152","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.humpath.2020.07.010","volume":"103","author":"D Mamilla","year":"2020","unstructured":"Mamilla D, Manukyan I, Fetsch PA, Pacak K, Miettinen M (2020) Immunohistochemical distinction of paragangliomas from epithelial neuroendocrine tumors-gangliocytic duodenal and cauda equina paragangliomas align with epithelial neuroendocrine tumors. Hum Pathol 103: 72-82. https:\/\/doi.org\/10.1016\/j.humpath.2020.07.010.","journal-title":"Hum Pathol"},{"key":"9708_CR153","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/nan.12713","volume":"47","author":"M Bockmayr","year":"2021","unstructured":"Bockmayr M, Korner M, Schweizer L, Schuller U (2021) Cauda equina paragangliomas express HOXB13. Neuropathol Appl Neurobiol 47: 889-890. https:\/\/doi.org\/10.1111\/nan.12713.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"9708_CR154","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1038\/s41436-020-0921-3","volume":"22","author":"SE Greenberg","year":"2020","unstructured":"Greenberg SE, Jacobs MF, Wachtel H, Anson A, Buchmann L, Cohen DL, Bonanni M, Bennett B, Naumer A, Schaefer AM, Kohlmann W, Nathanson KL, Else T, Fishbein L (2020) Tumor detection rates in screening of individuals with SDHx-related hereditary paraganglioma-pheochromocytoma syndrome. Genet Med 22: 2101-2107. https:\/\/doi.org\/10.1038\/s41436-020-0921-3.","journal-title":"Genet Med"},{"key":"9708_CR155","doi-asserted-by":"publisher","first-page":"5257312","DOI":"10.1155\/2016\/5257312","volume":"2016","author":"Y Okubo","year":"2016","unstructured":"Okubo Y, Yokose T, Motohashi O, Miyagi Y, Yoshioka E, Suzuki M, Washimi K, Kawachi K, Nito M, Nemoto T, Shibuya K, Kameda Y (2016) Duodenal Rare Neuroendocrine Tumor: Clinicopathological Characteristics of Patients with Gangliocytic Paraganglioma. Gastroenterol Res Pract 2016: 5257312. https:\/\/doi.org\/10.1155\/2016\/5257312","journal-title":"Gastroenterol Res Pract"},{"key":"9708_CR156","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/modpathol.3880561","volume":"15","author":"KR Torske","year":"2002","unstructured":"Torske KR, Thompson LD (2002) Adenoma versus carcinoid tumor of the middle ear: a study of 48 cases and review of the literature. Mod Pathol 15: 543-555. https:\/\/doi.org\/10.1038\/modpathol.3880561","journal-title":"Mod Pathol"},{"key":"9708_CR157","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/019131201300004717","volume":"25","author":"S Ketabchi","year":"2001","unstructured":"Ketabchi S, Massi D, Franchi A, Vannucchi P, Santucci M (2001) Middle ear adenoma is an amphicrine tumor: why call it adenoma? Ultrastruct Pathol 25: 73-78. https:\/\/doi.org\/10.1080\/019131201300004717","journal-title":"Ultrastruct Pathol"},{"key":"9708_CR158","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00428-017-2155-6","volume":"471","author":"D Bell","year":"2017","unstructured":"Bell D, El-Naggar AK, Gidley PW (2017) Middle ear adenomatous neuroendocrine tumors: a 25-year experience at MD Anderson Cancer Center. Virchows Arch 471: 667-672. https:\/\/doi.org\/10.1007\/s00428-017-2155-6","journal-title":"Virchows Arch"},{"key":"9708_CR159","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000180970","volume":"29","author":"JC Reubi","year":"1988","unstructured":"Reubi JC, Lamberts SW, Maurer R (1988) Somatostatin receptors in normal and tumoral tissue. Horm Res 29: 65-69.","journal-title":"Horm Res"},{"key":"9708_CR160","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/modpathol.2016.217","volume":"30","author":"B Konukiewitz","year":"2017","unstructured":"Konukiewitz B, Schlitter AM, Jesinghaus M, Pfister D, Steiger K, Segler A, Agaimy A, Sipos B, Zamboni G, Weichert W, Esposito I, Pfarr N, Kloppel G (2017) Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20. Mod Pathol 30: 587-598. https:\/\/doi.org\/10.1038\/modpathol.2016.217.","journal-title":"Mod Pathol"},{"key":"9708_CR161","doi-asserted-by":"publisher","unstructured":"Di Stasio GD, Buonomano P, Travaini LL, Grana CM, Mansi L (2021) From the Magic Bullet to Theragnostics: Certitudes and Hypotheses, Trying to Optimize the Somatostatin Model Cancers (Basel) 13.https:\/\/doi.org\/10.3390\/cancers13143474","DOI":"10.3390\/cancers13143474"},{"key":"9708_CR162","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00259-018-3967-6","volume":"45","author":"L Bodei","year":"2018","unstructured":"Bodei L, Kidd MS, Singh A, van der Zwan WA, Severi S, Drozdov IA, Cwikla J, Baum RP, Kwekkeboom DJ, Paganelli G, Krenning EP, Modlin IM (2018) PRRT genomic signature in blood for prediction of (177)Lu-octreotate efficacy. Eur J Nucl Med Mol Imaging 45: 1155-1169. https:\/\/doi.org\/10.1007\/s00259-018-3967-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9708_CR163","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000444803","volume":"104","author":"A Vanoli","year":"2017","unstructured":"Vanoli A, La Rosa S, Klersy C, Grillo F, Albarello L, Inzani F, Maragliano R, Manca R, Luinetti O, Milione M, Doglioni C, Rindi G, Capella C, Solcia E (2017) Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 Cases. Neuroendocrinology 104: 112-125. https:\/\/doi.org\/10.1159\/000444803.","journal-title":"Neuroendocrinology"},{"key":"9708_CR164","doi-asserted-by":"publisher","unstructured":"Kasajima A, Papotti M, Ito W, Brizzi MP, La SA, Rapa I, Tachibana T, Yazdani S, Sasano H, Volante M (2018) High interlaboratory and interobserver agreement of somatostatin receptor immunohistochemical determination and correlation with response to somatostatin analogs. Hum Pathol 72: 144\u2013152. S0046\u20138177(17)30427\u20136 ; https:\/\/doi.org\/10.1016\/j.humpath.2017.11.008.","DOI":"10.1016\/j.humpath.2017.11.008"},{"key":"9708_CR165","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/modpathol.3800954","volume":"20","author":"M Volante","year":"2007","unstructured":"Volante M, Brizzi MP, Faggiano A, La Rosa S, Rapa I, Ferrero A, Mansueto G, Righi L, Garancini S, Capella C, De RG, Dogliotti L, Colao A, Papotti M (2007) Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol 20: 1172-1182. https:\/\/doi.org\/10.1038\/modpathol.3800954.","journal-title":"Mod Pathol"},{"key":"9708_CR166","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1158\/1078-0432.CCR-16-1113","volume":"23","author":"AD Singhi","year":"2017","unstructured":"Singhi AD, Liu TC, Roncaioli JL, Cao D, Zeh HJ, Zureikat AH, Tsung A, Marsh JW, Lee KK, Hogg ME, Bahary N, Brand RE, McGrath KM, Slivka A, Cressman KL, Fuhrer K, O'Sullivan RJ (2017) Alternative Lengthening of Telomeres and Loss of DAXX\/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors. Clin Cancer Res 23: 600-609. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-1113.","journal-title":"Clin Cancer Res"},{"key":"9708_CR167","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1053\/j.gastro.2013.10.020","volume":"146","author":"I Marinoni","year":"2014","unstructured":"Marinoni I, Kurrer AS, Vassella E, Dettmer M, Rudolph T, Banz V, Hunger F, Pasquinelli S, Speel EJ, Perren A (2014) Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors. Gastroenterology 146: 453-460.","journal-title":"Gastroenterology"},{"key":"9708_CR168","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJMoa2005651","volume":"383","author":"LJ Wirth","year":"2020","unstructured":"Wirth LJ, Sherman E, Robinson B, Solomon B, Kang H, Lorch J, Worden F, Brose M, Patel J, Leboulleux S, Godbert Y, Barlesi F, Morris JC, Owonikoko TK, Tan DSW, Gautschi O, Weiss J, de la Fouchardiere C, Burkard ME, Laskin J, Taylor MH, Kroiss M, Medioni J, Goldman JW, Bauer TM, Levy B, Zhu VW, Lakhani N, Moreno V, Ebata K, Nguyen M, Heirich D, Zhu EY, Huang X, Yang L, Kherani J, Rothenberg SM, Drilon A, Subbiah V, Shah MH, Cabanillas ME (2020) Efficacy of Selpercatinib in RET-Altered Thyroid Cancers. N Engl J Med 383: 825-835. https:\/\/doi.org\/10.1056\/NEJMoa2005651.","journal-title":"N Engl J Med"},{"key":"9708_CR169","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1158\/1078-0432.CCR-16-3135","volume":"23","author":"S Hijioka","year":"2017","unstructured":"Hijioka S, Hosoda W, Matsuo K, Ueno M, Furukawa M, Yoshitomi H, Kobayashi N, Ikeda M, Ito T, Nakamori S, Ishii H, Kodama Y, Morizane C, Okusaka T, Yanagimoto H, Notohara K, Taguchi H, Kitano M, Yane K, Maguchi H, Tsuchiya Y, Komoto I, Tanaka H, Tsuji A, Hashigo S, Kawaguchi Y, Mine T, Kanno A, Murohisa G, Miyabe K, Takagi T, Matayoshi N, Yoshida T, Hara K, Imamura M, Furuse J, Yatabe Y, Mizuno N (2017) Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study. Clin Cancer Res 23: 4625-4632. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-3135.","journal-title":"Clin Cancer Res"},{"key":"9708_CR170","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1158\/1078-0432.CCR-17-1921","volume":"24","author":"JL Derks","year":"2018","unstructured":"Derks JL, Leblay N, Thunnissen E, van Suylen RJ, den BM, Groen HJM, Smit EF, Damhuis R, van den Broek EC, Charbrier A, Foll M, McKay JD, Fernandez-Cuesta L, Speel EM, Dingemans AC (2018) Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome. Clin Cancer Res 24: 33-42. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1921.","journal-title":"Clin Cancer Res"},{"key":"9708_CR171","doi-asserted-by":"publisher","unstructured":"Lacombe\u00a0C, RO De A, Couvelard A, Turpin A, Cazes O, Hentic V, Gounant G, Zalcman P, Ruszniewski J, Cros de ML (2021) Biomarkers of Response to Etoposide-Platinum Chemotherapy in Patients with Grade 3 Neuroendocrine Neoplasms Cancers (Basel) 13.https:\/\/doi.org\/10.3390\/cancers13040643","DOI":"10.3390\/cancers13040643"},{"key":"9708_CR172","doi-asserted-by":"crossref","unstructured":"Duan K, Mete O (2017) Familial endocrine tumor syndromes: Clinical and predictive roles of molecular histopathology. AJSP: Reviews and Reports 22: 246\u2013268.","DOI":"10.1097\/PCR.0000000000000206"},{"key":"9708_CR173","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00428-013-1465-6","volume":"463","author":"H Gucer","year":"2013","unstructured":"Gucer H, Szentgyorgyi E, Ezzat S, Asa SL, Mete O (2013) Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau disease. Virchows Arch 463: 593-597.","journal-title":"Virchows Arch"},{"key":"9708_CR174","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41379-019-0343-4","volume":"33","author":"J Favier","year":"2020","unstructured":"Favier J, Meatchi T, Robidel E, Badoual C, Sibony M, Nguyen AT, Gimenez-Roqueplo AP, Burnichon N (2020) Carbonic anhydrase 9 immunohistochemistry as a tool to predict or validate germline and somatic VHL mutations in pheochromocytoma and paraganglioma-a retrospective and prospective study. Mod Pathol 33: 57-64. https:\/\/doi.org\/10.1038\/s41379-019-0343-4.","journal-title":"Mod Pathol"},{"key":"9708_CR175","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001715","author":"O Mete","year":"2021","unstructured":"Mete O, Pakbaz S, Lerario AM, Giordano TJ, Asa SL (2021) Significance of Alpha-inhibin Expression in Pheochromocytomas and Paragangliomas. Am J Surg Pathol. https:\/\/doi.org\/10.1097\/PAS.0000000000001715.","journal-title":"Am J Surg Pathol"},{"key":"9708_CR176","doi-asserted-by":"publisher","unstructured":"Sekine R, Shimazu K, Nakano D, Yamaguchi T, Suzuki Y, Fukuda K, Yoshida T, Taguchi D, Iijima K, Nanjyo H, Shibata H (2022) A novel Lynch syndrome pedigree bearing germ-line MSH2 missense mutation c.1808A>T (Asp603Val). Jpn J Clin Oncol 52: 81\u201385. 6425237; https:\/\/doi.org\/10.1093\/jjco\/hyab173.","DOI":"10.1093\/jjco\/hyab173"},{"key":"9708_CR177","doi-asserted-by":"publisher","unstructured":"Karamurzin Y, Zeng Z, Stadler ZK, Zhang L, Ouansafi I, Al-Ahmadie HA, Sempoux C, Saltz LB, Soslow RA, O'Reilly EM, Paty PB, Coit DG, Shia J, Klimstra DS (2012) Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature. Hum Pathol 43: 1677\u20131687. S0046\u20138177(11)00518\u20131; https:\/\/doi.org\/10.1016\/j.humpath.2011.12.012.","DOI":"10.1016\/j.humpath.2011.12.012"},{"key":"9708_CR178","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.humpath.2011.12.012","volume":"43","author":"Y Karamurzin","year":"2012","unstructured":"Karamurzin Y, Zeng Z, Stadler ZK, Zhang L, Ouansafi I, Al Ahmadie HA, Sempoux C, Saltz LB, Soslow RA, O'Reilly EM, Paty PB, Coit DG, Shia J, Klimstra DS (2012) Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature. Hum Pathol 43: 1677-1687.","journal-title":"Hum Pathol"},{"key":"9708_CR179","doi-asserted-by":"publisher","unstructured":"Serracant BA, Serra PS, Blazquez Mana CM, Salas RC, Garcia MN, Bejarano GN, Romaguera MA, Andreu Navarro FJ, Bella Cueto MR, Borobia FG (2017) Pancreatic non-functioning neuroendocrine tumor: a new entity genetically related to Lynch syndrome. J Gastrointest Oncol 8: E73-E79. https:\/\/doi.org\/10.21037\/jgo.2017.07.02\/jgo-08-05-E73.","DOI":"10.21037\/jgo.2017.07.02\/jgo-08-05-E73"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-022-09708-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-022-09708-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-022-09708-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T03:00:02Z","timestamp":1647658802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-022-09708-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":179,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["9708"],"URL":"https:\/\/doi.org\/10.1007\/s12022-022-09708-2","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"28 January 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All authors consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Dr. Guido Rindi has had speaker engagements for the Advanced Accelerator Applications (AAA), a Novartis company. Dr. Shereen Ezzat has had speaker engagements for Novartis and Ipsen. Dr. David Klimstra is the Chief Medical officer (employee and equity holder) of Paige.AI. Dr. Ozgur Mete is the Editor-in-Chief of <i>Endocrine Pathology<\/i>. An independent senior editor handled this article and peer reviewed as per the journal standards. The remaining authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}